𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Favorable outcome with chemo-immunotherapy in Burkitt lymphoma and leukemia

✍ Scribed by Laimonas Griskevicius; Rokas Stulpinas; Indre Vengalyte; Sonata Saulyte-Trakymiene; Ugnius Mickys; Darius Pranys; Juozas Kurtinaitis; Mindaugas Jurgutis

Publisher
Elsevier Science
Year
2009
Tongue
English
Weight
109 KB
Volume
33
Category
Article
ISSN
0145-2126

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Consolidation and maintenance immunother
Consolidation and maintenance immunotherapy with rituximab improve clinical outcome in patients with B-cell chronic lymphocytic leukemia
✍ Giovanni Del Poeta; Maria Ilaria Del Principe; Francesco Buccisano; Luca Maurill πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 186 KB πŸ‘ 1 views

## Abstract ## BACKGROUND. Rituximab in sequential combination with fludarabine (Flu) allowed patients with B‐cell chronic lymphocytic leukemia (B‐CLL) to achieve higher remission rates and longer response duration. Based on their recent experience in indolent non‐Hodgkin lymphomas, in this study,

Epoetin alpha decreases the number of er
Epoetin alpha decreases the number of erythrocyte transfusions in patients with acute lymphoblastic leukemia, lymphoblastic lymphoma, and Burkitt leukemia/lymphoma : Results of a randomized clinical trial
✍ Maria E. Cabanillas; Hagop Kantarjian; Deborah A. Thomas; Gloria N. Mattiuzzi; M πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 415 KB

## Abstract ## BACKGROUND: Anemia is an expected consequence of intensive chemotherapy regimens administered to patients with acute leukemia. This study was designed to determine whether epoetin alpha would decrease the number of transfusion events and units of packed erythrocytes (PRBCs) transfus